Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.48B | 32.70B | 32.86B | 33.10B | 32.36B | 24.44B |
Gross Profit | 5.86B | 5.45B | 5.32B | 4.42B | 5.88B | 4.56B |
EBITDA | 1.82B | 1.56B | 1.31B | 532.00M | 1.78B | 1.35B |
Net Income | 987.00M | 522.00M | 220.00M | -444.00M | 811.00M | 501.00M |
Balance Sheet | ||||||
Total Assets | 40.56B | 37.52B | 40.11B | 38.55B | 40.09B | 35.89B |
Cash, Cash Equivalents and Short-Term Investments | 3.52B | 2.94B | 3.82B | 2.96B | 3.50B | 3.15B |
Total Debt | 7.93B | 7.13B | 7.58B | 10.16B | 9.96B | 8.91B |
Total Liabilities | 21.08B | 18.52B | 21.64B | 21.60B | 23.09B | 19.67B |
Stockholders Equity | 18.27B | 17.79B | 17.29B | 15.86B | 15.94B | 15.21B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -889.00M | 2.80B | -593.00M | -705.00M | -680.00M |
Operating Cash Flow | 0.00 | -224.00M | 3.58B | 104.00M | 1.08B | 1.25B |
Investing Cash Flow | 0.00 | -174.00M | -60.00M | -659.00M | -1.60B | -1.71B |
Financing Cash Flow | 0.00 | -513.00M | -2.60B | -3.00M | 861.00M | 519.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥6.86B | 11.75 | 2.67% | 6.93% | -6.22% | ||
75 Outperform | ¥17.88B | 6.99 | 4.53% | 0.79% | 60.97% | ||
74 Outperform | ¥17.38B | 11.07 | 2.45% | 5.96% | 182.60% | ||
71 Outperform | ¥23.94B | 7.25 | 3.07% | 9.75% | 28.00% | ||
70 Outperform | ¥175.99B | 11.22 | 6.29% | 3.46% | 3.94% | 5.74% | |
66 Neutral | ¥8.14B | 5.26 | 1.51% | 11.14% | 148.17% | ||
60 Neutral | ¥7.61B | 15.07 | 1.47% | -0.49% | 137.27% |